To save researchers time and resources, The Michael J. Fox Foundation has made a number of tools available to the scientific community at low cost, with rapid delivery.
Helpful Resources
-
Sponsored Tools Program
Learn more about how MJFF can help share your tools.
-
Tools Consortium
MJFF is working with industry to develop priority tools.
-
Preclinical Models
Learn more about the various in vivo models used in Parkinson's disease research.
Find a Research Tool
Filter by Tool Type or Gene/Protein Type to Organize Results
* = MJFF does not control pricing or terms of availability for this tool.
Filters
TMEM115 Antibody
Antibody
Rabbit monoclonal antibody directed against humanTMEM115 for immunoprecipitation of endogenous Golgi (tagless Golgi-IP).This antibody development project is part of the Aligning Science Across Parkinson’s (ASAP) Initiative.
ATP13A2 Antibody
Antibody
Rabbit monoclonal antibody directed against human ATP13A2 for immunoblotting applications. The epitope of this antibody was mapped to AA581-586. This antibody development project is part of the Aligning Science Across Parkinson’s (ASAP) Initiative. Estimated Availability: Early 2026
ATP13A2 Antibody
Antibody
Rabbit monoclonal antibody directed against mouse ATP13A2 for for immunoblotting applications. The epitope of this antibody was mapped to AA1029-1036. This antibody development project is part of the Aligning Science Across Parkinson’s (ASAP) Initiative. Estimated Availability: Early 2026
ATP13A2 Antibody
Antibody
Rabbit monoclonal antibody directed against human ATP13A2 for immunoblotting, immunostaining, and immunoprecipitation applications. This antibody development project is part of the Aligning Science Across Parkinson’s (ASAP) Initiative. Estimated Availability: Early 2026
Have questions or need additional information?
Email tools@michaeljfox.org with questions and to suggest new tools for us to develop. Or visit our FAQ page.
"We have shown, thanks in part to MJFF, that researchers now have in their pantry the right ‘ingredients’, to... help to drive forward PD drug development.”
Heather Melrose, PhD
Mayo Clinic